Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.37B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$488M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$449M |
| 4 |
Apple
AAPL
|
+$402M |
| 5 |
HES
Hess
HES
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.47B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$783M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.76% |
| 2 | Technology | 8.34% |
| 3 | Healthcare | 6.09% |
| 4 | Financials | 5% |
| 5 | Consumer Discretionary | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
iShares US Financials ETF
IYF
$4.31B
| $1.35M | ﹤0.01% |
15,835
+3,712
| +31% | +$289K |
|
3827
Theravance Biopharma
TBPH
$885M
| $1.35M | ﹤0.01% |
120,165
-107,498
| -47% | -$1.08M |
|
3828
Albany International
AIN
$1.66B
| $1.35M | ﹤0.01% |
13,723
-115,496
| -89% | -$10.1M |
|
3829
KB Financial Group
KB
$43.6B
| $1.35M | ﹤0.01% |
32,560
-8,781
| -21% | -$355K |
|
|
EXAS
3830
PUT
DELISTED
Exact Sciences
EXAS
| $1.35M | ﹤0.01% |
18,200
-106,400
| -85% | -$6.97M |
|
|
KNTE
3831
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $1.34M | ﹤0.01% |
564,932
+7,674
| +1% | +$13.6K |
|
|
DCH
3832
PUT
Dauch Corp
DCH
$1.5B
| $1.34M | ﹤0.01% |
151,600
+29,300
| +24% | +$217K |
|
|
RPTX
3833
DELISTED
Repare Therapeutics
RPTX
| $1.33M | ﹤0.01% |
182,097
+159,410
| +703% | +$892K |
|
3834
CALL
Integer Holdings
ITGR
$4.26B
| $1.33M | ﹤0.01% |
+13,400
| New | +$1.15M |
|
3835
Karyopharm Therapeutics
KPTI
$42.4M
| $1.33M | ﹤0.01% |
102,284
+27,757
| +37% | +$374K |
|
|
VGR
3836
DELISTED
Vector Group Ltd.
VGR
| $1.32M | ﹤0.01% |
117,347
-90,980
| -44% | -$987K |
|
3837
VF Corp
VFC
$5.37B
| $1.32M | ﹤0.01% |
+70,356
| New | +$1.21M |
|
|
ONC
3838
BeOne Medicines Ltd
ONC
$41.5B
| $1.32M | ﹤0.01% |
7,324
-39,783
| -84% | -$7.2M |
|
3839
Valvoline
VVV
$4.1B
| $1.32M | ﹤0.01% |
35,087
-489,471
| -93% | -$16.4M |
|
3840
Medallion Financial
MFIN
$274M
| $1.32M | ﹤0.01% |
133,503
-63,445
| -32% | -$527K |
|
3841
PUT
Coherent
COHR
$54.7B
| $1.31M | ﹤0.01% |
+30,200
| New | +$1.09M |
|
3842
CALL
StoneCo
STNE
$2.24B
| $1.31M | ﹤0.01% |
+72,900
| New | +$958K |
|
|
MURA
3843
DELISTED
Mural Oncology
MURA
| $1.31M | ﹤0.01% |
+221,441
| New | +$890K |
|
|
CLBR.U
3844
DELISTED
Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CLBR.U
| $1.31M | ﹤0.01% |
+130,000
| New | +$1.31M |
|
3845
Installed Building Products
IBP
$6.53B
| $1.31M | ﹤0.01% |
7,163
-38,338
| -84% | -$5.38M |
|
3846
PUT
Everest Group
EG
$14.5B
| $1.31M | ﹤0.01% |
3,700
| – | – |
|
3847
The Greenbrier Companies
GBX
$1.42B
| $1.31M | ﹤0.01% |
29,587
-137,006
| -82% | -$5.36M |
|
3848
Alaska Air
ALK
$4.72B
| $1.3M | ﹤0.01% |
33,400
-284,032
| -89% | -$10.1M |
|
3849
Lifeway Foods
LWAY
$398M
| $1.3M | ﹤0.01% |
97,250
+75,245
| +342% | +$950K |
|
3850
Navient
NAVI
$887M
| $1.3M | ﹤0.01% |
70,002
-298,508
| -81% | -$5.21M |
|
Similar funds
Israel Englander's Q4 2023 Portfolio in Review
As of Q4 2023, Israel Englander held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander's Q4 2023 filing shows 816 new, 2,304 increased, 2,388 reduced and 883 closed positions. Its largest new stake was Ferguson: 906,589 shares worth $175M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
- Israel Englander's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
- Israel Englander fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
- Israel Englander's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
- Israel Englander opened 816 new positions and closed 883 in Q4 2023.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $231B.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.